Multidisciplinary Care in High-Risk Prostate Cancer Is the New Standard of Care
J Clin Oncol
.
2019 May 10;37(14):1143-1147.
doi: 10.1200/JCO.19.00298.
Epub 2019 Mar 22.
Authors
Rahul R Parikh
1
,
Biren Saraiya
1
Affiliation
1
1 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
PMID:
30901303
DOI:
10.1200/JCO.19.00298
No abstract available
Publication types
Editorial
Comment
MeSH terms
Docetaxel*
Humans
Male
Medical Oncology
Prostatic Neoplasms*
Standard of Care
Substances
Docetaxel